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On January 14, the ESA probe
Huygens touched down on the
strangest place ever visited by a
man-made object, Saturn’s moon
Titan. The data that Huygens
recorded in a few hours of
mission time will keep researchers
busy for years, trying to figure out
the details of that strange world.
Looking back over the seven
years and three months that the
space voyage lasted, the planet
from which Cassini-Huygens
blasted off on October 15 1997
appears almost as unfamiliar as
Titan. Bill Clinton was in the White
House, and a young, bushy-tailed
Tony Blair had just moved into
Downing Street in London. 
One of the issues that is nearly
forgotten now but was dominating
the headlines in October 1997 is
the human form of BSE. Originally
recorded as “variant
Creutzfeldt–Jakob disease”
(vCJD), this new form of the rare
prion disease CJD was found
predominantly in the UK, which
had just experienced a major
epidemic of BSE. Several lines of
circumstantial evidence pointed
towards a link between vCJD and
BSE, which the British
government initially denied but
then admitted in 1996. In October
1997, two papers in Nature
delivered conclusive evidence
that both diseases are in fact
caused by the same agent,
presumably transmitted through
infected beef products. 
In the late 1990s, case numbers
of the new disease climbed from
single figures to double figures
per year, reaching 28 in 2000.
Although the BSE epidemic in
cattle had been overcome by that
time, the long incubation time in
humans meant that there was no
way of knowing how many people
might have been infected. For all
that the scientists knew at the
time, the death toll might amount
to just 200, or to over 100,000
people in the long term. Now a
group of researchers at Imperial
College London have called off
the state of alert, predicting that
the number of future deaths from
transmission via food is likely to
be around 70, on top of the 146
who have already died from
human BSE in Britain by
November 2004. 
Epidemiologist Azra Ghani and
her co-workers analysed tissue
samples obtained from surgically
removed tonsils and appendices.
Earlier studies using this
approach had shown that the
infection can be traced from these
samples, but the numbers
involved were too small to allow
reliable predictions.
Ghani’s research, based on
samples from 12,764 patients, has
spotted three cases of infection in
this group. While this means that
up to 3,800 people in Britain may
be carrying the infection, the
epidemiologists estimate that only
around 70 of those will go on to
fall ill with the human form of BSE. 
In spite of the uncertainties that
still remain, this outlook is much
less frightening than previous
predictions. However, vigilance is
still required, as the
extrapolations in this research
apply to the direct transmission
from beef to human only (a route
that is now closed such that no
new infections will be added).
Additional risks arise from the fact
that thousands of carriers, most
of them unaware of the infection,
might pass on the prions via
blood donations or contamination
of surgical instruments. 
This risk of transfection
between humans was highlighted
recently, as the eighth ever
identified case of human BSE in
France turned out to be a frequent
blood donor. At least 10
recipients of blood transfusions
are thought to have been exposed
to the risk of BSE infection from
this person. However, it has been
established that the other seven
known cases have not been blood
donors, such that the overall
situation appears to be under
control. 
Only a few other countries,
including the US, Canada, Ireland,
and Italy have one or two
confirmed cases of vCJD, such
that there is only a very small risk
of a further spread. Ireland, for
example, has only recently
identified the first case believed
to originate in the country (as
opposed to the previous case of
an Irish woman who had lived in
Britain during the BSE epidemic).
Like many other countries, Ireland
bans everybody who has lived in
Britain between 1980 and 1996
from donating blood. 
Until recently, the risk of
transmission of BSE by blood
transfusion was a controversial
issue. The first case of a vCJD
victim infected by a blood
transfusion was only confirmed in
December 2003. As infectious
prions are difficult to test for and
tend to resist common
sterilization procedures, this new
human to human transmission
route poses a considerable
challenge to the health system of
Britain with its suspected pool of
unidentified carriers.
A year ago, an editorial in the
British Medical Journal called for
strict measures to register all
potential infections and patients
who have been exposed to
infectious agents. 
Not much appears to have
happened since, as the world
appeared to have more pressing
problems. After calling off the
alert on infections via the food
chain, one should heighten the
awareness of the risk of patient-
to-patient infection, in order to
ensure that in another seven
years this new disease of seven
years ago will have become
history. 
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Alarm bells rang eight years ago with the evidence that mad cow disease
could pass from cows to humans via the food chain. But new research
suggests that the disease, although still a problem in a number of
countries, will have a limited effect on the human population. Michael
Gross reports. 
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